| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of Sertoli–Leydig cell tumor in a postmenopausal woman
|
CARINGELLA, A.
|
|
2006
|
16 |
1 |
p. 435-438
|
artikel
|
| 2 |
A cytohistologic study of atypical glandular cells detected in cervical smears during cervical screening tests in Iran
|
MOOD, N. IZADI
|
|
2006
|
16 |
1 |
p. 257-261
|
artikel
|
| 3 |
A decreasing incidence of ovarian carcinoma in Israel
|
MENCZER, J.
|
|
2006
|
16 |
1 |
p. 41-44
|
artikel
|
| 4 |
Aggressive angiomyxoma of the female pelvis and perineum: a case series
|
MAGTIBAY, P.M.
|
|
2006
|
16 |
1 |
p. 396-401
|
artikel
|
| 5 |
A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer
|
D’AGOSTINO, G
|
|
2006
|
16 |
1 |
p. 71-76
|
artikel
|
| 6 |
Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials
|
BAI, F.
|
|
2006
|
16 |
1 |
p. 202-209
|
artikel
|
| 7 |
An analysis of surgical versus chemotherapeutic intervention for the management of intestinal obstruction in advanced ovarian cancer
|
BRYAN, D.N.
|
|
2006
|
16 |
1 |
p. 125-134
|
artikel
|
| 8 |
A pilot study of three-cycle consolidation chemotherapy with paclitaxel and platinum in epithelial ovarian cancer patients with clinical complete response after paclitaxel and platinum chemotherapy
|
LEE, S.-J.
|
|
2006
|
16 |
1 |
p. 95-100
|
artikel
|
| 9 |
A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers
|
BENOIT, M.F.
|
|
2006
|
16 |
1 |
p. 29-35
|
artikel
|
| 10 |
CA19-9 may have clinical significance in mature cystic teratomas of the ovary
|
DEDE, M.
|
|
2006
|
16 |
1 |
p. 189-193
|
artikel
|
| 11 |
Carcinosarcoma arising from atypical endometriosis in a cesarean section scar
|
LENG, J.
|
|
2006
|
16 |
1 |
p. 432-435
|
artikel
|
| 12 |
Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma
|
ARAI, T.
|
|
2006
|
16 |
1 |
p. 391-395
|
artikel
|
| 13 |
Clinical significance of N-acetyl- l-aspartate resonance in ovarian mucinous cystadenoma
|
HASCALIK, S.
|
|
2006
|
16 |
1 |
p. 423-426
|
artikel
|
| 14 |
Comparison of diagnostic usefulness of predictive models in preliminary differentiation of adnexal masses
|
MOSZYNSKI, R.
|
|
2006
|
16 |
1 |
p. 45-51
|
artikel
|
| 15 |
Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients
|
BOZKURT, N.
|
|
2006
|
16 |
1 |
p. 83-86
|
artikel
|
| 16 |
Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero
|
HAJEK, R.A.
|
|
2006
|
16 |
1 |
p. 318-324
|
artikel
|
| 17 |
Development of anticancer gene vaccine interact with human papillomavirus oncoprotein inhibition
|
AHN, W.S.
|
|
2006
|
16 |
1 |
p. 270-276
|
artikel
|
| 18 |
Difficult clinical decisions in gynecological oncology: identifying priorities for future clinical research
|
HARRISON, J.D.
|
|
2006
|
16 |
1 |
p. 1-7
|
artikel
|
| 19 |
Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis
|
CHANG, K.-H
|
|
2006
|
16 |
1 |
p. 178-182
|
artikel
|
| 20 |
Efficacy and tolerability of the ifosfamide–epirubicin combination in relapsed ovarian cancer
|
JOLY, F.
|
|
2006
|
16 |
1 |
p. 77-82
|
artikel
|
| 21 |
Erratum
|
|
|
2006
|
16 |
1 |
p. 461
|
artikel
|
| 22 |
Ethnicity is a factor to be considered before dose planning in ovarian cancer patients to be treated with topotecan
|
TAM, K.F.
|
|
2006
|
16 |
1 |
p. 135-139
|
artikel
|
| 23 |
Evidence of human papillomavirus infection, enhanced phosphorylation of retinoblastoma protein, and decreased apoptosis in sarcomatoid squamous cell carcinoma of uterine cervix
|
LIN, C.-P.
|
|
2006
|
16 |
1 |
p. 336-340
|
artikel
|
| 24 |
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?
|
RASPOLLINI, M.R.
|
|
2006
|
16 |
1 |
p. 416-422
|
artikel
|
| 25 |
Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters
|
KAYASELCUK, F.
|
|
2006
|
16 |
1 |
p. 402-408
|
artikel
|
| 26 |
Gonadotropins and ovarian carcinogenesis: a new era of basic research and its clinical implications
|
KONISHI, I.
|
|
2006
|
16 |
1 |
p. 16-22
|
artikel
|
| 27 |
Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium
|
EDMONDSON, R.J.
|
|
2006
|
16 |
1 |
p. 171-177
|
artikel
|
| 28 |
Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells
|
GIELEN, S.C.J.P.
|
|
2006
|
16 |
1 |
p. 110-120
|
artikel
|
| 29 |
HER-2 codon 655 polymorphism in cervical carcinogenesis
|
UEDA, M.
|
|
2006
|
16 |
1 |
p. 325-328
|
artikel
|
| 30 |
Hormonal function after ovarian transposition to the abdominal subcutaneous fat tissue
|
NAGAO, S.
|
|
2006
|
16 |
1 |
p. 121-124
|
artikel
|
| 31 |
How can we predict ureteral obstruction after gynecological surgery? The changes in Doppler resistive index and plasma creatinine and magnesium concentrations after surgical, unilateral ureteral obstruction in a rabbit model
|
TEREK, M.C.
|
|
2006
|
16 |
1 |
p. 376-379
|
artikel
|
| 32 |
HOXB homeobox gene expression in cervical carcinoma
|
LÓPEZ, R.
|
|
2006
|
16 |
1 |
p. 329-335
|
artikel
|
| 33 |
Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand
|
SRIAMPORN, S.
|
|
2006
|
16 |
1 |
p. 266-269
|
artikel
|
| 34 |
Induction of G1 arrest and differentiation in MDA-MB-231 breast cancer cell by boehmeriasin A, a novel compound from plant
|
YAN, J.
|
|
2006
|
16 |
1 |
p. 165-170
|
artikel
|
| 35 |
Irregularly shaped inclusion cysts display increased expression of Ki67, Fas, Fas ligand, and procaspase-3 but relatively little active caspase-3
|
SLOT, K.A.
|
|
2006
|
16 |
1 |
p. 231-239
|
artikel
|
| 36 |
Large-cell neuroendocrine carcinoma of the cervix associated with cervical-type invasive adenocarcinoma: a report of case and discussion of histogenesis
|
CETINER, H.
|
|
2006
|
16 |
1 |
p. 438-442
|
artikel
|
| 37 |
Long-standing complications after treatment for cancer of the uterine cervix—clinical significance of medical examination at 5 years after treatment
|
MATSUURA, Y.
|
|
2006
|
16 |
1 |
p. 294-297
|
artikel
|
| 38 |
Malignant mixed müllerian tumors of the ovary: experience with cytoreductive surgery and platinum-based combination chemotherapy
|
MOK, J.E.
|
|
2006
|
16 |
1 |
p. 101-105
|
artikel
|
| 39 |
Malignant transformation of ovarian mature cystic teratoma
|
RIM, S.-Y.
|
|
2006
|
16 |
1 |
p. 140-144
|
artikel
|
| 40 |
Metastatic Hurthle cell carcinoma in the abdomen masquerading as a primary ovarian tumor: a case report
|
AL-KHATIB, K.
|
|
2006
|
16 |
1 |
p. 429-432
|
artikel
|
| 41 |
Metastatic uterine leiomyosarcoma coexisting with papillary carcinoma of the thyroid gland
|
GIANNIKAKI, E.
|
|
2006
|
16 |
1 |
p. 442-445
|
artikel
|
| 42 |
Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer
|
WILEY, A.
|
|
2006
|
16 |
1 |
p. 210-218
|
artikel
|
| 43 |
Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies
|
MELICHAR, B.
|
|
2006
|
16 |
1 |
p. 240-252
|
artikel
|
| 44 |
Ovarian cancer in pregnancy: a clinicopathologic analysis of 22 cases and review of the literature
|
ZHAO, X.Y.
|
|
2006
|
16 |
1 |
p. 8-15
|
artikel
|
| 45 |
Ovarian endometrioid carcinoma with diffuse pigmented peritoneal keratin granulomas: a case report and review of the literature
|
WU, T.I.
|
|
2006
|
16 |
1 |
p. 426-429
|
artikel
|
| 46 |
Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia
|
ISHIKAWA, M.
|
|
2006
|
16 |
1 |
p. 347-353
|
artikel
|
| 47 |
Oxygenated and reoxygenated tumors show better local control in radiation therapy for cervical cancer
|
SUZUKI, Y.
|
|
2006
|
16 |
1 |
p. 306-311
|
artikel
|
| 48 |
Paclitaxel–platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial
|
UTSUNOMIYA, H.
|
|
2006
|
16 |
1 |
p. 52-56
|
artikel
|
| 49 |
Pelvic exenteration without external urinary or fecal diversion in gynecological cancer patients
|
UNGAR, L.
|
|
2006
|
16 |
1 |
p. 364-368
|
artikel
|
| 50 |
Pelvic floor dysfunction and radical hysterectomy
|
JACKSON, K.S.
|
|
2006
|
16 |
1 |
p. 354-363
|
artikel
|
| 51 |
Perioperative morbidity and mortality of gynecological oncologic surgery in elderly women
|
BEN-AMI, I.
|
|
2006
|
16 |
1 |
p. 452-457
|
artikel
|
| 52 |
p63 expression in epithelial ovarian tumors
|
POLI NETO, O.B.
|
|
2006
|
16 |
1 |
p. 152-155
|
artikel
|
| 53 |
Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer
|
TIERSTEN, A.
|
|
2006
|
16 |
1 |
p. 57-64
|
artikel
|
| 54 |
Phase II study of the American Brachytherapy Society guidelines for the use of high–dose rate brachytherapy in the treatment of cervical carcinoma: is 45–50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high–dose rate brachytherapy tolerable?
|
SHAKESPEARE, T.P.
|
|
2006
|
16 |
1 |
p. 277-282
|
artikel
|
| 55 |
Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer
|
VERHAAR-LANGEREIS, M.
|
|
2006
|
16 |
1 |
p. 65-70
|
artikel
|
| 56 |
Preclinical in vivo activity of a combination gemcitabine/liposomal doxorubicin against cisplatin-resistant human ovarian cancer (A2780/CDDP)
|
GALLO, D.
|
|
2006
|
16 |
1 |
p. 222-230
|
artikel
|
| 57 |
Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section
|
SANJUÁN, A.
|
|
2006
|
16 |
1 |
p. 385-390
|
artikel
|
| 58 |
Primary malignant mesodermal ovarian sarcomas
|
GARI, A.
|
|
2006
|
16 |
1 |
p. 106-109
|
artikel
|
| 59 |
Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy
|
NAM, J.H.
|
|
2006
|
16 |
1 |
p. 23-28
|
artikel
|
| 60 |
Procaspase-3 enhances the in vitro effect of cytosine deaminase–thymidine kinase disuicide gene therapy on human ovarian cancer
|
SONG, Y.
|
|
2006
|
16 |
1 |
p. 156-164
|
artikel
|
| 61 |
Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay
|
GALLION, H.
|
|
2006
|
16 |
1 |
p. 194-201
|
artikel
|
| 62 |
Prophylactic salpingo-oophorectomy in 51 women with familial breast–ovarian cancer: importance of fallopian tube dysplasia
|
LEUNEN, K.
|
|
2006
|
16 |
1 |
p. 183-188
|
artikel
|
| 63 |
Response to the letter of Barton
|
|
|
2006
|
16 |
1 |
p. 459-460
|
artikel
|
| 64 |
Role of human papillomavirus DNA testing in management of women with atypical squamous cells of undetermined significance
|
KIATPONGSAN, S.
|
|
2006
|
16 |
1 |
p. 262-265
|
artikel
|
| 65 |
Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulva
|
LAND, R.
|
|
2006
|
16 |
1 |
p. 312-317
|
artikel
|
| 66 |
Routine follow-up after treatment for a gynecological cancer: a survey of practice
|
KEW, F.M.
|
|
2006
|
16 |
1 |
p. 380-384
|
artikel
|
| 67 |
Sampling the omentum in ovarian neoplasia: when one block is enough
|
DOIG, T.
|
|
2006
|
16 |
1 |
p. 36-40
|
artikel
|
| 68 |
Sensitivity to cisplatin determined by the histoculture drug response assay and clinical response of endometrial cancer
|
KANASUGI, M.
|
|
2006
|
16 |
1 |
p. 409-415
|
artikel
|
| 69 |
Should punch biopsies be used when high-grade disease is suspected at initial colposcopic assessment? A prospective study
|
BYROM, J.
|
|
2006
|
16 |
1 |
p. 253-256
|
artikel
|
| 70 |
Suppression of telomerase activity and arrest at G1 phase in human cervical cancer HeLa cells by all-trans retinoic acid
|
GUO, J.M.
|
|
2006
|
16 |
1 |
p. 341-346
|
artikel
|
| 71 |
The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin™) in chemoresistant ovarian cancer cells
|
MENENDEZ, J.A.
|
|
2006
|
16 |
1 |
p. 219-221
|
artikel
|
| 72 |
Tirapazamine plus cisplatin in advanced or recurrent carcinoma of the uterine cervix: a Southwest Oncology Group study
|
SMITH, H.O.
|
|
2006
|
16 |
1 |
p. 298-305
|
artikel
|
| 73 |
Tissue microarray analysis of EGFR and erbB2 copy number changes in ovarian tumors
|
DIMOVA, I.
|
|
2006
|
16 |
1 |
p. 145-151
|
artikel
|
| 74 |
To the Editor
|
|
|
2006
|
16 |
1 |
p. 458
|
artikel
|
| 75 |
Unilateral groin and pelvic irradiation for unilaterally node-positive women with vulval carcinoma
|
JACKSON, K.S.
|
|
2006
|
16 |
1 |
p. 283-287
|
artikel
|
| 76 |
Urodynamic study on postsurgical bladder function in cervical cancer treated with systematic nerve-sparing radical hysterectomy
|
TODO, Y.
|
|
2006
|
16 |
1 |
p. 369-375
|
artikel
|
| 77 |
Use of Prolene Mesh in surgical treatment of tissue defects after radical inguinal and pelvic lymph node dissection in vulvar cancer—a brief report
|
OLEJEK, A.
|
|
2006
|
16 |
1 |
p. 448-451
|
artikel
|
| 78 |
Uterine lipoma and coincidental cervical cancer: a case report
|
DILEK, T.U.K.
|
|
2006
|
16 |
1 |
p. 445-447
|
artikel
|
| 79 |
Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix
|
BRAND, A.H.
|
|
2006
|
16 |
1 |
p. 288-293
|
artikel
|
Tijdschrift beschrijving